UBS analyst AJ Rice upgraded Enhabit Home Health & Hospice (NYSE: EHAB) from Neutral to Buy with a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE